{"id":21,"date":"2008-03-31T11:15:13","date_gmt":"2008-03-31T15:15:13","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/cto\/head-neck\/"},"modified":"2024-09-24T15:24:42","modified_gmt":"2024-09-24T19:24:42","slug":"head-neck","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/head-neck\/","title":{"rendered":"Head &amp; Neck"},"content":{"rendered":"<h3 style=\"text-align: center;\">Head &amp; Neck Squamous Cell Carcinoma<\/h3>\n<p><a href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01810913?term=NCT01810913&amp;rank=1\"><strong>CIRB #H-32379\/ RTOG #R1216<\/strong>:<\/a> Randomized Phase II\/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck<\/p>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04333537?term=NCT04333537&amp;draw=2&amp;rank=1\"><strong>CIRB # H-41338\/ NRG #HN006<\/strong>:<\/a> Randomized Phase II\/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer<\/p>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03952585?term=NCT03952585&amp;draw=2&amp;rank=1\"><strong>CIRB # H-39827\/ NRG #HN005<\/strong>:<\/a> Randomized Phase II\/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, p16-Positive, Non-Smoking Associated Oropharyngeal Cancer <b>(temporary closure)<\/b><\/p>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03546582?term=NCT03546582&amp;rank=1\"><strong>IRB #H-38134\/ RTOG Foundation #R3507 (KEYSTROKE)<\/strong>:<\/a> A Randomized phase II study of Pembrolizumab (<strong>KEY<\/strong>TRUDA\u00ae) plus <strong>ST<\/strong>e<strong>R<\/strong>e<strong>O<\/strong>tactic Re-Irradiation versus SBRT alone for Locoregionally Recurrent or Second Primary Head and N<strong>E<\/strong>c<strong>K<\/strong> Carcinoma<\/p>\n<h3 style=\"text-align: center;\">Nasopharyngeal<\/h3>\n<p><a href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT06457503?term=NCT06457503&amp;rank=1\"><strong>IRB #H-45017\/ RTOG Foundation #CHS-007-01\/RTOG 3521 (TRANSPARENT)<\/strong>:<\/a> Single-Arm Study of Toripalimab in Combination with Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Na\u00efve Participants <b>(pending IRB)<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Head &amp; Neck Squamous Cell Carcinoma CIRB #H-32379\/ RTOG #R1216: Randomized Phase II\/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck CIRB # H-41338\/ NRG #HN006: Randomized Phase II\/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral [&hellip;]<\/p>\n","protected":false},"author":1006,"featured_media":0,"parent":0,"menu_order":21,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages\/21"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/users\/1006"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/comments?post=21"}],"version-history":[{"count":51,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages\/21\/revisions"}],"predecessor-version":[{"id":5487,"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/pages\/21\/revisions\/5487"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/clinicaltrials\/wp-json\/wp\/v2\/media?parent=21"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}